– USA, TX – Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz to its Board of Directors effective immediately.
About Maria Sainz
Ms. Sainz brings to our Board over 20 years of medical device and management experience from both Silicon Valley start-ups and large medical device companies. During the period from 2008 until early this year, she served as the CEO of three innovative MedTech start-ups. One of these companies was acquired by CooperSurgical in 2021 and another was acquired by Stryker Corporation in 2011. At Stryker, she led the Business Unit that comprised her former company. From 1998 to 2006, Ms. Sainz held several leadership positions at Guidant Corporation, including President of the Cardiac Surgery division, VP, Global Marketing for the Vascular Intervention Division, and VP of the Intermedics Cardiac Rhythm Management business in Europe. From 2006 to 2008, Ms. Sainz led integration activities following the acquisition of Guidant by Boston Scientific.
Ms. Sainz serves as a director of two other public companies, ShockWave Medical, and Avanos Medical. We are proud to add Ms. Sainz to our Board.
About Atrion Corporation
Atrion Corporation develops and manufactures products primarily for medical applications.
For more information: https://www.atrioncorp.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.